Stock Titan Trading tools for traders and investors.

-

08:49:32 AM

Last JAGX Stock Market News

JAGX - Jaguar Health Inc

01/15/21 8:30 AM

NASDAQ : JAGX

Jaguar Health Provides Replay Link & High-level Overview of January 14th Investor Webcast

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today provided the replay link for the Company's January 14, 2021 investor webcast and a recap of the key points from the presentation. To access the audio recording and slides from the

RHEA-AI

neutral

01/13/21 8:00 AM

NASDAQ : JAGX

Jaguar Health Announces $15 Million Registered Direct Offering Priced Above-the-Market Under Nasdaq Rules

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced it has entered into a securities purchase agreement with two institutional investors including a high-net-worth family office for the purchase and sale of 4,437,870

RHEA-AI

neutral

01/13/21 8:00 AM

NASDAQ : JAGX

Jaguar Health Enters Non-dilutive Binding Term Sheet for $6.0 Million Sale of Partial Rights to Possible Tropical Disease Priority Review Voucher

This additional non-dilutive financing will support development program for lechlemer for the indication of the symptomatic relief of diarrhea and dehydration in cholera patients REMINDER: Jaguar-hosted investor webcast scheduled for Thursday, January 14 at 11:30 A.M. Eastern Time. Webcast

RHEA-AI

neutral

01/12/21 8:30 AM

NASDAQ : JAGX

Jaguar Health to Present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference the Week of January 11th and at 4:30 pm Eastern on Tuesday, January 19th at the NobleCon17 Virtual Conference

Jaguar Health, Inc. (NASDAQ:JAGX)

RHEA-AI

neutral

01/11/21 8:30 AM

NASDAQ : JAGX

Jaguar Health Exploring Possibility of Conditional Marketing Authorization for Proposed Inflammatory Diarrhea Indication for Crofelemer, Initially in 'Long-Hauler' COVID-19 Recovery Patients in Europe

Jaguar Health, Inc.

RHEA-AI

neutral

01/06/21 8:30 AM

NASDAQ : JAGX

Jaguar Health Subsidiary Receiving Preclinical Services from the National Institute of Allergy and Infectious Diseases for New Preclinical Study Initiated January 6, 2021 for Lechlemer Plant-Based Drug Candidate for the Symptomatic Relief of Diarrhea from Cholera

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") announced today that the 28-day preclinical toxicology and safety study in dogs began today, January 6,

RHEA-AI

neutral

12/23/20 8:30 AM

NASDAQ : JAGX

Jaguar Health Signs Second Agreement for $6 Million Non-dilutive Financing Transaction Involving the Sale of Royalty Rights Related to Future Mytesi (Crofelemer) and Lechlemer Revenue Stream

No royalty payments due for 18-24 months Proceeds will be allocated to support regulatory activities associated with the Company's development pipeline, including funding the recently initiated pivotal clinical trial for crofelemer (Mytesi (R)) for cancer therapy-related diarrhea (CTD), for which

RHEA-AI

very positive

12/22/20 12:00 PM

NASDAQ : JAGX

Jaguar Health Reports Voting Results from Special Meeting of Stockholders & Announces December 23rd Investor Webinar

All proposals approved Company not implementing a reverse split at this time Swiss Growth Forum hosting investor webinar Wednesday, December 23rd at 10:30 AM Eastern regarding appearance of new coronavirus strain underscoring urgency to seek European conditional approval for crofelemer for

RHEA-AI

neutral

12/10/20 8:30 AM

NASDAQ : JAGX

Jaguar Health Announces Adjournment of Its Special Meeting of Stockholders Until Tuesday, December 22, 2020

Jaguar to Host Investor Call Thursday, December 17th at 8:30 a.m. Eastern to Allow Management to Review Developments that Have Taken Place Since the Definitive Proxy Statement was Filed As previously announced, Nasdaq's Listing and Hearing Review Council Stayed the Panel Determination Requiring

RHEA-AI

very positive

12/07/20 8:30 AM

NASDAQ : JAGX

Nasdaq's Listing and Hearing Review Council Stays Panel Determination Requiring Jaguar Health's Compliance with the Bid Price Requirement by December 23, 2020

Jaguar Health, Inc. (Nasdaq:JAGX)

RHEA-AI

very positive

Prev 1 2 3 4 5 Next